Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2
Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2…
December 1, 2022 - 2 minutes
ISA Pharmaceuticals
ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy
ISA Pharmaceuticals B.V, a Netherlands-based clinical stage biotech developing immunotherapies to treat cancers and infectious…
November 8, 2022 - 2 minutes
Dutch and US Biotechs Team Up Against HPV-related Cancer
ISA Pharmaceuticals will work together with Regeneron to combine its immunotherapy against cancer induced by…
December 18, 2017 - 2 minutes
Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!
Known for its charming canals and tulip fields, Leiden is a major tourist attraction in…
February 28, 2017 - 7 minutes
7 European Institutions in the Largest Cancer Bioinformatics Collaboration
Europe's best companies using bioinformatics to tackle cancer will take part in a huge collaboration…
December 1, 2016 - 2 minutes
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
CAR-T therapies have gained plenty of attention lately by promising to end cancer with a one-off…
September 29, 2016 - 5 minutes
Reviewing Immuno-Oncology: What works and what doesn’t
Researchers from Leiden University Medical Center (LUMC) and ISA Pharmaceuticals (Netherlands) have authored an extensive review…
March 11, 2016 - 4 minutes
